![]() |
市场调查报告书
商品编码
1562276
到 2030 年北美门诊中央履行市场预测 - 区域分析 - 按产品类型和最终用户North America Outpatient Central Fulfillment Market Forecast to 2030 - Regional Analysis - by Product Type and End User |
2022年北美门诊中央履行市价为1.5256亿美元,预计2030年将达3.505亿美元;预计2022年至2030年复合年增长率为11.0%。
药局自动化推动北美门诊中央履行市场
药房自动化已成为医疗保健产业最蓬勃发展的领域之一。自动化技术可以透过自动化药局任务和流程来改善患者护理并提高效率。根据 Visionary Insights 的一项研究,预计到 2021 年,药房的自动化程度每年将增长 22%。 Oracle Cerner 的一项研究表明,特殊药物的自动配药是药局执行最多的任务之一。研究还指出,药房自动化可以提高准确性(并减少错误)、加快流程并改善患者护理。药剂师也采用技术来自动化配药以外的某些其他任务,例如库存管理。自动化库存系统可以帮助药房更准确地追踪和管理库存。
领先的药房自动化系统供应商不断致力于开发和推出他们的创新。 2021 年 2 月,Omnicell Inc. 宣布推出 Medimat,这是一种适用于零售药房的下一代自动配药系统。它的建立是为了提高病人安全、有效利用时间和节省资金。同样,2021 年 8 月,创新 Aspirations (iA) 是一家软体支援的药房履行和自动化解决方案商业提供商,推出了三款与 Medimat 的 NEXiA 技术集成的解决方案,以集中管理处方药的履行。 iA 还推出了 SmartPod,这是一款具有模组化自动填充单元的下一代机器人。 SmartPod 让药局供应商调整和扩展其集中履行解决方案。因此,随着下一代自动化系统的引入,药局越来越多地采用自动化,推动了门诊中央履行市场的成长。
北美门诊中央履行市场概览
美国门诊中央履行市场的成长主要是由于用药错误的增加和药物需求的激增。美国患者人数的增加表明大量患者每天服用多种药物。服用多种药物的患者发生用药错误的风险增加,可能会对患者造成健康风险。因此,医疗机构依赖自动化系统等现代技术来避免用药错误。因此,对精确机器人设备和工具以更快地执行任务的需求预计将成为市场成长的关键因素。据Zippia称,2021年美国製药业创造了550亿美元的收入,占全球製药市场的48%。因此,美国主导了医药市场,呈现需求和药物开发不断增长的趋势。
北美门诊中央履行市场收入及 2030 年预测(百万美元)
北美门诊中心履行市场区隔
北美门诊中央履行市场根据产品类型、最终用户和国家进行细分。根据产品类型,北美门诊中央履行市场分为自动配药系统、自动包装和标籤系统、自动桌面柜檯、自动储存和检索系统等。 2022 年,自动配药系统领域占据最大的市场份额。
从最终用户来看,北美门诊集中履行市场分为医院药局、零售药局和邮购药局。 2022年,医院药局领域占据最大的市场份额。
根据国家/地区,北美门诊中央履行市场分为美国、加拿大和墨西哥。 2022 年,美国在北美门诊中心履行市场份额中占据主导地位。
Tension Envelope Corp、ScriptPro LLC、Cardinal Health Inc、Omnicell Inc、Becton Dickinson and Co、RxSafe LLC、Custom Health Inc、Capsa Solutions LLC、Surescripts LLC 和 McKesson Corp 是北美门诊中心履行领域的一些领先参与者市场。
The North America outpatient central fulfillment market was valued at US$ 152.56 million in 2022 and is expected to reach US$ 350.50 million by 2030; it is estimated to record a CAGR of 11.0% from 2022 to 2030.
Automation in Pharmacies Drives North America Outpatient Central Fulfillment Market
Pharmacy automation has become one of the most flourishing segments of the healthcare sector. The automation technology can improve patient care and increase efficiency by automating pharmacy tasks and processes. According to a study by Visionary Insights, automation in pharmacies was predicted to increase by 22% each year through 2021. This rise can be attributed to the growing need for precise and efficient dispensing, and the increasing number of specialty medication dispensing operations. A study by Oracle Cerner states that the automated dispensing of specialty medications was one of the most performed tasks in pharmacies. The study also states that pharmacy automation can improve accuracy (and reduce errors), speed up the process, and improve patient care. Pharmacists also adopt technologies to automate certain other tasks than dispensing, e.g., inventory management. Automated inventory systems can help pharmacies track and manage their inventory more accurately.
Leading pharmacy automation system vendors continuously focus on developing and introducing their innovations. In February 2021, Omnicell Inc. announced the launch of its Medimat, a next-generation, automated dispensing system for retail pharmacies. It has been built for improved patient safety, efficient time utilization, and financial savings. Similarly, in August 2021, innovative Aspirations (iA), a commercial provider of software-enabled pharmacy fulfillment and automation solutions, launched three solutions integrated with Medimat's NEXiA technology to manage the fulfillment of prescribed medicines centrally. iA has also introduced SmartPod, a next-generation robot with a modular autofill unit. SmartPod allows pharmacy providers to adjust and scale their centralized fulfillment solutions. Thus, the growing adoption of automation in pharmacies with the introduction of next-generation automated systems fuels the growth of the outpatient central fulfillment market.
North America Outpatient Central Fulfillment Market Overview
The outpatient central fulfillment market in the US is growing mainly with the rising medication errors and surging demand for pharmaceutical products. An increased patient population in the US indicates a large number of patients taking multiple medicines daily. Patients who take multiple medications are at an increased risk of medication errors, which can cause health risks in patients. Therefore, healthcare organizations rely on modern technologies such as automation systems to avoid medication errors. As a result, the demand for precise robotic equipment and tools to perform tasks faster are expected to be the key factors for market growth. According to Zippia, in 2021 the pharmaceutical industry in the US generated US$ 55 billion, accounting to 48% of the global pharmaceutical market. Thus, the US dominated the pharmaceutical market, exhibiting a growing trend in demand and drug development.
North America Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
North America Outpatient Central Fulfillment Market Segmentation
The North America outpatient central fulfillment market is segmented based on product type, end user, and country. Based on product type, the North America outpatient central fulfillment market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated tabletop counters, automated storage and retrieval systems, and others. The automated medication dispensing systems segment held the largest market share in 2022.
In terms of end user, the North America outpatient central fulfillment market is categorized into hospital pharmacies, retail pharmacies, and mail-order pharmacies. The hospital pharmacies segment held the largest market share in 2022.
Based on country, the North America outpatient central fulfillment market is segmented into the US, Canada, and Mexico. The US dominated the North America outpatient central fulfillment market share in 2022.
Tension Envelope Corp, ScriptPro LLC, Cardinal Health Inc, Omnicell Inc, Becton Dickinson and Co, RxSafe LLC, Custom Health Inc, Capsa Solutions LLC, Surescripts LLC, and McKesson Corp are some of the leading players operating in the North America outpatient central fulfillment market.